|
|
|
StaphAseptic™ News
Cystic Fibrosis Patients with MRSA Have Shorter Survival
June 16, 2010
Kansas City Info Zine
Patients with cystic fibrosis (CF) who have Methicillin-resistant Staphylococcus aureus (MRSA) detected in their respiratory tract have worse survival compared to CF patients without MRSA.
Chicago, IL - infoZine - The most common cause of death in CF is respiratory failure secondary to pulmonary infection. The prevalence of MRSA in the respiratory tract of individuals with CF has increased substantially, and is now more than 20 percent, according to background information to a study in the June 16 issue of JAMA. However, the effect of MRSA on outcomes in CF is unclear.
Elliott C. Dasenbrook, M.D., M.H.S., of Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, and colleagues conducted a study to examine the association between MRSA and survival in CF. The study included 19,833 CF patients (ages 6 to 45 years) who were enrolled in the study January 1996 and December 2006, with follow-up until December 2008. Various analytic models were used to compare survival between CF patients with and without respiratory tract MRSA.
This is a portion of the original article. To keep reading, visit infozine.com
|
|
|
